Drugs@FDA document

LETAIRIS Review · NDA 022081 ORIG-1

Drugs@FDA document · GILEAD · Aug 21, 2007

Key facts

Drug name LETAIRIS
Document type Review
Application NDA022081
Submission ORIG-1
Company GILEAD
Document date Aug 21, 2007
FDA document accessdata.fda.gov

At a glance

  • Clinical Pharmacology Review Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents